Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

gemcitabine injection solution Principal Display Panel

PRINCIPAL DISPLAY PANEL - 1 g/26.3 mL Vial Label

Gemcitabine Injection

1 g/26.3 mL

(38 mg/mL)

For Intravenous Infusion Only
Must Be Diluted Before Use
Store at 2 to 8°C (36 to 46°F)
26.3 mL Single-Dose Vial.
Discard unused portion.

Principal Display Panel - 1 g/26.3 mL Vial Label

PRINCIPAL DISPLAY PANEL - 1 g/26.3 mL Vial Carton

Rx only
NDC 0409-0181-01

Gemcitabine
Injection

1 g/26.3 mL

(38 mg/mL)

For Intravenous Infusion Only
Must Be Diluted Before Use
Store at 2 to 8°C (36 to 46°F)
26.3 mL Single-Dose Vial
Discard Unused Portion

Caution: Cytotoxic Agent

Principal Display Panel - 1 g/26.3 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 200 mg/5.26 mL Vial Label

Gemcitabine Injection

200 mg/5.26 mL

(38 mg/mL)

For Intravenous Infusion Only
Must Be Diluted Before Use
Store at 2 to 8°C (36 to 46°F)
5.26 mL Single-Dose Vial.
Discard unused portion.

Principal Display Panel - 200 mg/5.26 mL Vial Label

PRINCIPAL DISPLAY PANEL - 200 mg/5.26 mL Vial Carton

Rx only
NDC 0409-0183-01

Gemcitabine
Injection

200 mg/5.26 mL

(38 mg/mL)

For Intravenous Infusion Only
Must Be Diluted Before Use
Store at 2 to 8°C (36 to 46°F)
5.26 mL Single-Dose Vial
Discard Unused Portion

Caution: Cytotoxic Agent

Principal Display Panel - 200 mg/5.26 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 2 g/52.6 mL Vial Label

Gemcitabine Injection

2 g/52.6 mL

(38 mg/mL)

For Intravenous Infusion Only
Must Be Diluted Before Use
Store at 2 to 8°C (36 to 46°F)
52.6 Single-Dose Vial.
Discard unused portion.

Principal Display Panel - 2 g/52.6 mL Vial Label

PRINCIPAL DISPLAY PANEL - 2 g/52.6 mL Vial Carton

Rx only
NDC 0409-0182-01

Gemcitabine
Injection

2 g/52.6 mL

(38 mg/mL)

For Intravenous Infusion Only
Must Be Diluted Before Use
Store at 2 to 8°C (36 to 46°F)
52.6 mL Single-Dose Vial
Discard Unused Portion

Caution: Cytotoxic Agent

Principal Display Panel - 2 g/52.6 mL Vial Carton
Show All Hide All
Show All Hide All
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event
Pfizer Safety

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.

FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.